Switch to
More onapp

How to use scorecard? Learn more

Lotus Eye Hospital and Institute Ltd

LOTUSEYE
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹157 cr, stock is ranked 2,722
High RiskStock is 4.21x as volatile as Nifty
75.100.86 (-1.13%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹157 cr, stock is ranked 2,722
High RiskStock is 4.21x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
114.47
PB RatioPB Ratio
2.66
Dividend YieldDiv. Yield
Sector PESector PE
51.53
Sector PBSector PB
6.56
Sector Div YldSctr Div Yld
0.52%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Lotus Eye Hospital and Institute Limited is engaged in the provision of healthcare services. The Company is engaged in the field of ophthalmology (eye) and its related operation.

Financial TrendFinancial statements 

202120222023202433.2039.8048.1949.521.572.994.092.91
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 1.36%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Clarification - Financial Results 
Announced OnDec 7, 2024
The Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 30-Sep-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
The Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 30-Sep-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Copy of Newspaper Publication 
Announced OnNov 14, 2024

Lotus Eye Hospital and Institute Limited has informed the Exchange about Copy of Newspaper Publication | Download

Lotus Eye Hospital and Institute Limited has informed the Exchange about Copy of Newspaper Publication | Download

Cash Dividend 
Ex. DateSep 18, 2023

Final • Div/Share: ₹ 0.5

See all events